AI Article Synopsis
Article Abstract
[This corrects the article DOI: 10.1017/qrd.2022.6.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392616 | PMC |
| http://dx.doi.org/10.1017/qrd.2022.8 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to 'Raising awareness of alcohol as a modifiable risk factor for breast cancer: A randomized controlled trial comparing the efficacy of accessing an interactive website with a non-interactive website' [The Breast (2025) 103868].
Breast
January 2025
Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Italy. Electronic address:
Corrigendum to "Neural evidence of implicit emotion regulation deficits: An explorative study of comparing PTSD with and without alcohol dependence" [J. Affect. Disord. 372 (2025) 548-563].
J Affect Disord
January 2025
Key Laboratory of Adolescent Cyberpsychology and Behavior (Ministry of Education), Key Laboratory of Human Development and Mental Health of Hubei Province, School of Psychology, Central China Normal University, Wuhan, China. Electronic address:
Correction to: A comparative study of Cu‑based nanoparticles and their spin‑coated films: photocatalytic degradation mechanisms and efficiencies towards malachite green and neutral red azo dyes.
Environ Sci Pollut Res Int
January 2025
Institute of Forestry and Engineering, Estonian University of Life Sciences, 51014, Tartu, Estonia.
Corrigendum to "Clinical utility of PCR compared to conventional culture & sensitivity testing for the management of complicated urinary tract infections in adults:Part I. Assessment of clinical outcomes,investigator satisfaction scores & turnaround times" [Diagnostic Microbiology & Infectious Disease 111 (2025) 116601].
Diagn Microbiol Infect Dis
January 2025
MED-US Consulting, LLC., Austin, TX, United States.
Correction: Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET study.
Neuropsychopharmacology
January 2025
Neurocrine Biosciences, Inc., San Diego, CA, USA.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!